- Report
- August 2024
- 120 Pages
Global
From €5165EUR$5,950USD£4,478GBP
- Report
- July 2023
- 90 Pages
India
From €3429EUR$3,950USD£2,973GBP
- Report
- November 2024
- 110 Pages
United States
From €5165EUR$5,950USD£4,478GBP
- Report
- August 2024
- 120 Pages
Global
From €5165EUR$5,950USD£4,478GBP
- Report
- May 2024
- 128 Pages
Global
From €3471EUR$3,999USD£3,009GBP
- Report
- May 2024
- 200 Pages
Global
From €3602EUR$4,150USD£3,123GBP
- Report
- March 2024
- 200 Pages
Global
From €3602EUR$4,150USD£3,123GBP
- Report
- January 2025
- 175 Pages
Global
From €3897EUR$4,490USD£3,379GBP
- Report
- January 2025
- 175 Pages
Global
From €3897EUR$4,490USD£3,379GBP
- Report
- January 2025
- 175 Pages
Global
From €3897EUR$4,490USD£3,379GBP
- Report
- April 2023
- 180 Pages
Global
From €2821EUR$3,250USD£2,446GBP
- Report
- January 2025
- 175 Pages
Global
From €3897EUR$4,490USD£3,379GBP
- Report
- January 2025
- 175 Pages
Global
From €3897EUR$4,490USD£3,379GBP
- Report
- January 2025
- 175 Pages
Global
From €3897EUR$4,490USD£3,379GBP
- Report
- November 2024
- 88 Pages
India
From €3038EUR$3,500USD£2,634GBP
- Report
- August 2024
- 80 Pages
Saudi Arabia
From €3038EUR$3,500USD£2,634GBP
- Report
- October 2023
- 90 Pages
India
From €3038EUR$3,500USD£2,634GBP
- Report
- April 2023
- 112 Pages
Global
From €4123EUR$4,750USD£3,575GBP
- Report
- October 2022
- 110 Pages
Global
From €4123EUR$4,750USD£3,575GBP
- Report
- December 2024
- 150 Pages
Global
From €3255EUR$3,750USD£2,822GBP

Uveitis is a medical condition that affects the uvea, the middle layer of the eye. It is characterized by inflammation of the uvea, which can lead to vision loss and other complications. In the context of optical, uveitis is a major cause of vision loss and can be treated with a variety of treatments, including topical and systemic medications, laser treatments, and surgery.
Uveitis is a growing market in the optical industry, as it is a common cause of vision loss and can be treated with a variety of treatments. Companies in the uveitis market include Bausch + Lomb, Novartis, Allergan, and Santen Pharmaceuticals. These companies offer a range of treatments for uveitis, including topical and systemic medications, laser treatments, and surgery. Show Less Read more